Dane Stevens
Tracked across 4 events · 52 articles · First seen Jan 26, 2026 · Last active Jun 10, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Impact: Dane Stevens, CEO of Optimi Health, highlighted the significance of the production and export runs in expanding access to psychedelic treatments in Australia.
Jan 26, 2026 · 6 articles
Business
Optimi Health, a pharmaceutical manufacturer, has announced it secured naturally derived ibogaine and will begin developing finished drug products this summer at its GMP facility in British Columbia, Canada. This initiative follows a U.S. Executive…
Impact: Dane Stevens, CEO and Co-Founder of Optimi Health, is leading the company's ibogaine initiative and highlights the growing interest and public funding for ibogaine research.
Jun 08, 2026 · 14 articles
Business
Cohen & Company Capital Markets, a subsidiary of Cohen & Company Capital Markets, announced the opening of a new office in United States — North Carolina, to expand its sales and trading presence. Sean Ladley,…
Impact: Dane Stevens will support Sean Ladley in the Charlotte office, overseeing Cohen & Company Capital Markets' preferred sales and trading team with deep expertise in preferred securities.
Jun 08, 2026 · 7 articles
Business
Optimi Health, a pharmaceutical manufacturer of regulated psychedelic drug products, has completed its first export of naturally derived psilocybin, including biomass and 5mg capsules, to the United Kingdom. This shipment will support a planned Phase…
Impact: Dane Stevens, CEO and Co-Founder of Optimi Health, highlighted the significance of the company's first shipment to the United Kingdom and its unique position as a vertically integrated GMP supplier.
Jun 02, 2026 · 25 articles
NEWSDESK
Track Dane Stevens live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard